Medicine

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

U. Nagele, Karl-Dietrich Sievert, M. Kuczyk, Arnulf Stenzl

2006.3.1EUROPEAN UROLOGY

DOI: 10.1016/j.eururo.2005.12.031

tlooto Summary

These probabilities allow urologists to easily calculate a superficial bladder cancer patient's short- and long-term risks of recurrence and progression after transurethral resection to determine the most appropriate treatment and frequency of follow-up.

Abstract

Abstract is not available.

Citation format

NAGELE, U., et al. Predicting recurrence and progression in individual patients with stage ta t1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. EUROPEAN UROLOGY, 2006, 49 3: 466–5;discussion475–7.